These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 1691493

  • 1. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
    Gottlieb C, Raju U, Greenwald KA.
    Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
    [Abstract] [Full Text] [Related]

  • 2. The role of immunocytochemical markers in the differential diagnosis of proliferative and neoplastic lesions of the breast.
    Joshi MG, Lee AK, Pedersen CA, Schnitt S, Camus MG, Hughes KS.
    Mod Pathol; 1996 Jan; 9(1):57-62. PubMed ID: 8821958
    [Abstract] [Full Text] [Related]

  • 3. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB, Lee MW, Zarbo RJ, Crissman JD.
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
    Hilson JB, Schnitt SJ, Collins LC.
    Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
    [Abstract] [Full Text] [Related]

  • 5. [Nodular sclerosing adenosis (adenosis tumor) of the breast. An immunohistologic study particularly in reference to the relationship with radial cicatrix and to the differential diagnosis with tubular carcinoma].
    Lanzafame S.
    Pathologica; 1989 Jun; 81(1073):251-66. PubMed ID: 2641538
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
    Masood S, Sim SJ, Lu L.
    Cancer Detect Prev; 1992 Jun; 16(4):225-35. PubMed ID: 1281040
    [Abstract] [Full Text] [Related]

  • 7. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ, Ebrahimsade S, Ramaswamy A, Moll R.
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [Abstract] [Full Text] [Related]

  • 8. Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions.
    Pavlakis K, Zoubouli C, Liakakos T, Messini I, Keramopoullos A, Athanassiadou S, Kafousi M, Stathopoulos EN.
    Breast; 2006 Dec; 15(6):705-12. PubMed ID: 16384708
    [Abstract] [Full Text] [Related]

  • 9. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.
    Gusterson BA, Warburton MJ, Mitchell D, Ellison M, Neville AM, Rudland PS.
    Cancer Res; 1982 Nov; 42(11):4763-70. PubMed ID: 6290045
    [Abstract] [Full Text] [Related]

  • 10. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH, Kuijpers HJ, Lane EB, Leigh IM, Troyanovsky SM, Holland R, van Haelst UJ, Ramaekers FC.
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical profile and differential diagnosis of microglandular adenosis.
    Tavassoli FA, Bratthauer GL.
    Mod Pathol; 1993 May; 6(3):318-22. PubMed ID: 8346180
    [Abstract] [Full Text] [Related]

  • 12. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T, Kim JY, Tavassoli FA.
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [Abstract] [Full Text] [Related]

  • 13. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
    Wada T, Yasutomi M, Yamada K, Hashimura K, Kunikata M, Tanaka T, Huang JW, Mori M.
    Anticancer Res; 1991 Apr; 11(6):1983-93. PubMed ID: 1723260
    [Abstract] [Full Text] [Related]

  • 15. [Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors].
    Gel'shteĭn VI, Chipysheva TA, Ermilova VD, Liubimov AV.
    Arkh Patol; 1990 Apr; 52(9):12-8. PubMed ID: 1702969
    [Abstract] [Full Text] [Related]

  • 16. Detection of basement membrane components and basal cell keratin 14 in noninvasive and invasive carcinomas of the breast.
    Wetzels RH, Holland R, van Haelst UJ, Lane EB, Leigh IM, Ramaekers FC.
    Am J Pathol; 1989 Mar; 134(3):571-9. PubMed ID: 2466404
    [Abstract] [Full Text] [Related]

  • 17. A theoretical rationale on the histogenesis of premalignant lesions and early carcinoma of the prostate.
    Botticelli AR.
    Pathologica; 1994 Apr; 86(2):128-41. PubMed ID: 7524011
    [Abstract] [Full Text] [Related]

  • 18. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
    Tan PH, Lui GG, Chiang G, Yap WM, Poh WT, Bay BH.
    Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
    [Abstract] [Full Text] [Related]

  • 19. Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.
    Raju U, Crissman JD, Zarbo RJ, Gottlieb C.
    Am J Surg Pathol; 1990 Oct; 14(10):939-47. PubMed ID: 1698341
    [Abstract] [Full Text] [Related]

  • 20. Immunohistochemical localization of S100 protein in benign and malignant conditions of the breast.
    Egan MJ, Newman J, Crocker J, Collard M.
    Arch Pathol Lab Med; 1987 Jan; 111(1):28-31. PubMed ID: 3026280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.